TY - JOUR
T1 - Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer
AU - Baiocchi, Gian Luca
AU - Marrelli, Daniele
AU - Verlato, Giuseppe
AU - Morgagni, Paolo
AU - Giacopuzzi, Simone
AU - Coniglio, Arianna
AU - Marchet, Alberto
AU - Rosa, Fausto
AU - Capponi, Michela Giulii
AU - Di Leo, Alberto
AU - Saragoni, Luca
AU - Ansaloni, Luca
AU - Pacelli, Fabio
AU - Nitti, Donato
AU - D'Ugo, Domenico
AU - Roviello, Franco
AU - Tiberio, Guido A. M.
AU - Giulini, Stefano M.
AU - De Manzoni, Giovanni
PY - 2014
Y1 - 2014
N2 - Background: The Italian Research Group for Gastric Cancer supports the practice of follow-up after radical surgery for gastric cancer. Methods: This multicenter, retrospective study (1998-2009) included patients with T1-4N0-3M0 gastric cancer who had undergone D2 gastrectomy and lymphadenectomy, with at least 15 lymph nodes examined, and who had developed recurrent disease. Timing and site of recurrence were correlated to the actual scheduled follow-up timing and modalities. Results: From eight centers, 814 patients with recurrent cancer and over 1,754 (46.4 %) patients undergoing gastrectomy were investigated (median follow-up 31 months). The most frequent sites of recurrence were local/regional lymph nodes (35.4 %), liver (24.3 %), peritoneum (30.3 %), lung (10.4 %) and intraluminal (7.5 %). Ninety-four percent of the recurrences were diagnosed within 2 years and 98 % within 3 years. Thoracoabdominal computed tomography (CT) scan and (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (18-FDG-PET) detected more than 90 % of recurrences, abdominal ultrasound detected 70 % and tumor markers detected 40 %, while <10 % were identified by physical examination, chest X-ray, and upper gastrointestinal endoscopy. Twenty-six percent of patients with recurrence were treated, but only 3.2 % were treated with potentially radical intent. Conclusion: Oncological follow-up after radical surgery for gastric cancer should be focused in the first 3 years, and based mainly on thoracoabdominal CT scan and 18-FDG-PET. © 2014 Society of Surgical Oncology.
AB - Background: The Italian Research Group for Gastric Cancer supports the practice of follow-up after radical surgery for gastric cancer. Methods: This multicenter, retrospective study (1998-2009) included patients with T1-4N0-3M0 gastric cancer who had undergone D2 gastrectomy and lymphadenectomy, with at least 15 lymph nodes examined, and who had developed recurrent disease. Timing and site of recurrence were correlated to the actual scheduled follow-up timing and modalities. Results: From eight centers, 814 patients with recurrent cancer and over 1,754 (46.4 %) patients undergoing gastrectomy were investigated (median follow-up 31 months). The most frequent sites of recurrence were local/regional lymph nodes (35.4 %), liver (24.3 %), peritoneum (30.3 %), lung (10.4 %) and intraluminal (7.5 %). Ninety-four percent of the recurrences were diagnosed within 2 years and 98 % within 3 years. Thoracoabdominal computed tomography (CT) scan and (18)F-fluoro-2-deoxy-d-glucose positron emission tomography (18-FDG-PET) detected more than 90 % of recurrences, abdominal ultrasound detected 70 % and tumor markers detected 40 %, while <10 % were identified by physical examination, chest X-ray, and upper gastrointestinal endoscopy. Twenty-six percent of patients with recurrence were treated, but only 3.2 % were treated with potentially radical intent. Conclusion: Oncological follow-up after radical surgery for gastric cancer should be focused in the first 3 years, and based mainly on thoracoabdominal CT scan and 18-FDG-PET. © 2014 Society of Surgical Oncology.
KW - gastric cancer
KW - gastric cancer
UR - http://hdl.handle.net/10807/64456
UR - http://www.scopus.com/inward/record.url?eid=2-s2.0-84893712908&partnerid=40&md5=588952a84c1409fd8d38491161188830
U2 - 10.1245/s10434-014-3534-8
DO - 10.1245/s10434-014-3534-8
M3 - Article
SN - 1068-9265
VL - 21
SP - 2005
EP - 2011
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
ER -